MTOR and familial pancreatic carcinoma: Because it has been previously reported that HHAT inhibition by RU-SKI 43 negatively affected Akt and mTOR pathways in pancreatic cancer cells [22], we also assessed the impact of RU-SKI 43 on Akt and mTOR pathways in SAS and eSAS cells.